
Elon Musk’s Neuralink receives Canadian approval for brain chip trial
(Reuters) – Elon Musk’s Neuralink said on Wednesday it has received approval to launch its first cli...
21st November, 2024

(Reuters) – Elon Musk’s Neuralink said on Wednesday it has received approval to launch its first cli...
21st November, 2024

LONDON (Reuters) – Manchester City forward Lauren Hemp faces a spell on the sidelines after undergoi...
19th November, 2024

HOUSTON (Reuters) – CareMax, which operates 56 medical centers in Florida, Texas, Tennessee and New...
18th November, 2024

By Shashwat Chauhan (Reuters) -Europe’s STOXX 600 fell on Friday, dragged by technology and healthca...
15th November, 2024

By Jennifer Rigby and Julie Steenhuysen LONDON (Reuters) – There are certain phrases that Wachuka Gi...
14th November, 2024

By Nancy Lapid (Reuters) – U.S. military veterans face racial and ethnic inequities in access to Nov...
11th November, 2024

The Global Platelet Agitator Market is projected to grow at a CAGR of 4.88% from 2024 to 2030, accor...
8th November, 2024

Seegene, Microsoft, and Springer Nature are collaborating on a global technology-sharing initiative...
8th November, 2024

ROME (Reuters) – The number of people aged over 100 in Italy has increased by 30% over the past 10 y...
8th November, 2024

LONDON (Reuters) – Novo Nordisk reported forecast-beating quarterly sales of its popular Wegovy weig...
6th November, 2024

LONDON (Reuters) -Queen Camilla, the wife of Britain’s King Charles, has been forced to pull out of...
6th November, 2024

By Sabrina Valle NEW YORK (Reuters) – Jeff Stute, a veteran investment banker with a career spanning...
4th November, 2024